Carla Estany

1.3k total citations
21 papers, 547 citations indexed

About

Carla Estany is a scholar working on Emergency Medicine, Infectious Diseases and Virology. According to data from OpenAlex, Carla Estany has authored 21 papers receiving a total of 547 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Emergency Medicine, 14 papers in Infectious Diseases and 6 papers in Virology. Recurrent topics in Carla Estany's work include HIV-related health complications and treatments (17 papers), HIV/AIDS drug development and treatment (10 papers) and HIV Research and Treatment (6 papers). Carla Estany is often cited by papers focused on HIV-related health complications and treatments (17 papers), HIV/AIDS drug development and treatment (10 papers) and HIV Research and Treatment (6 papers). Carla Estany collaborates with scholars based in Spain, Pakistan and United States. Carla Estany's co-authors include Bonaventura Clotet, Eugènia Negredo, Jordi Puig, Anna Bonjoch, Núria Pérez‐Álvarez, Patricia Echeverría, Silvana Di Gregorio, Luis del Río, Guadalupe Gómez Melis and José Ramón Santos and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and AIDS.

In The Last Decade

Carla Estany

21 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carla Estany Spain 12 349 267 142 122 104 21 547
Sherry Claxton United States 6 824 2.4× 444 1.7× 287 2.0× 454 3.7× 71 0.7× 6 963
Alan Macken Ireland 9 152 0.4× 105 0.4× 83 0.6× 57 0.5× 45 0.4× 12 298
Julia Purdy United States 14 348 1.0× 236 0.9× 100 0.7× 16 0.1× 184 1.8× 23 586
Janne Jensen Denmark 11 58 0.2× 181 0.7× 114 0.8× 48 0.4× 188 1.8× 19 512
G. Calvo Spain 3 356 1.0× 272 1.0× 174 1.2× 8 0.1× 46 0.4× 4 443
Tania Mudrikova Netherlands 12 64 0.2× 242 0.9× 104 0.7× 3 0.0× 248 2.4× 39 456
Matthew R. Gingo United States 16 312 0.9× 290 1.1× 59 0.4× 6 0.0× 583 5.6× 25 830
Jules Levin United States 4 467 1.3× 255 1.0× 143 1.0× 3 0.0× 83 0.8× 8 568
Yuaner Wu United States 7 176 0.5× 112 0.4× 116 0.8× 7 0.1× 46 0.4× 9 323
Pairoj Chattranukulchai Thailand 10 63 0.2× 58 0.2× 56 0.4× 6 0.0× 72 0.7× 67 410

Countries citing papers authored by Carla Estany

Since Specialization
Citations

This map shows the geographic impact of Carla Estany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carla Estany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carla Estany more than expected).

Fields of papers citing papers by Carla Estany

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carla Estany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carla Estany. The network helps show where Carla Estany may publish in the future.

Co-authorship network of co-authors of Carla Estany

This figure shows the co-authorship network connecting the top 25 collaborators of Carla Estany. A scholar is included among the top collaborators of Carla Estany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carla Estany. Carla Estany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Negredo, Eugènia, Cora Loste, Jordi Puig, et al.. (2021). Accentuated aging associated with HIV in a Mediterranean setting occurs mainly in persons aged>70 years: a comparative cohort study (Over50 cohort). AIDS Care. 34(2). 155–162. 4 indexed citations
2.
Loste, Cora, José Moltó, Núria Pérez‐Álvarez, et al.. (2020). Potential prescribing issues among older HIV‐infected subjects in a Mediterranean cohort: Does the current prevalence give cause for concern?. British Journal of Clinical Pharmacology. 87(3). 1310–1317. 11 indexed citations
3.
Puig, Jordi, Patricia Echeverría, Carla Estany, et al.. (2020). A Specific Mobile Health Application for Older HIV-Infected Patients: Usability and Patient's Satisfaction. Telemedicine Journal and e-Health. 27(4). 432–440. 21 indexed citations
4.
Negredo, Eugènia, Klaus Langohr, Anna Bonjoch, et al.. (2018). High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs. Journal of Antimicrobial Chemotherapy. 73(9). 2452–2459. 5 indexed citations
5.
Negredo, Eugènia, Vicente Estrada, Peré Domingo, et al.. (2016). Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals. Journal of Antimicrobial Chemotherapy. 72(3). dkw504–dkw504. 10 indexed citations
6.
Bonjoch, Anna, Patricia Echeverría, Núria Pérez‐Álvarez, et al.. (2016). Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity. BioMed Research International. 2016. 1–5. 5 indexed citations
7.
Negredo, Eugènia, Jordi Puig, Patricia Echeverría, et al.. (2015). Ten-Year Safety with Polyacrylamide Gel Used to Correct Facial Lipoatrophy in HIV-Infected Patients. AIDS Research and Human Retroviruses. 31(8). 817–821. 9 indexed citations
8.
Santos, José Ramón, María Saumoy, Adrián Curran, et al.. (2015). The Lipid-Lowering Effect of Tenofovir/Emtricitabine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial. Clinical Infectious Diseases. 61(3). 403–408. 96 indexed citations
9.
Negredo, Eugènia, Anna Bonjoch, Jordi Puig, et al.. (2015). Long-term changes in bone mineral density after switching to a protease inhibitor monotherapy in HIV-infected subject.. PubMed. 38(2). 193–9. 2 indexed citations
10.
Negredo, Eugènia, Anna Bonjoch, Núria Pérez‐Álvarez, et al.. (2015). Comparison of two different strategies of treatment with zoledronate in HIV‐infected patients with low bone mineral density: single dose versus two doses in 2 years. HIV Medicine. 16(7). 441–448. 15 indexed citations
11.
Santos, José Ramón, María Saumoy, Adrián Curran, et al.. (2014). Randomized, crossover, double‐blind, placebo‐controlled trial to assess the lipid lowering effect of co‐formulated TDF/FTC. Journal of the International AIDS Society. 17(4S3). 19550–19550. 5 indexed citations
12.
Bonjoch, Anna, Patricia Echeverría, Núria Pérez‐Álvarez, et al.. (2012). High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy. Antiviral Research. 96(1). 65–69. 39 indexed citations
13.
Negredo, Eugènia, Anna Bonjoch, Carla Estany, et al.. (2012). Time of Progression to Osteopenia/Osteoporosis in Chronically HIV-Infected Patients: Screening DXA Scan. PLoS ONE. 7(10). e46031–e46031. 15 indexed citations
14.
Negredo, Eugènia, Jordi Puig, Anna Bonjoch, et al.. (2012). Similarly high Prevalence of Hypovitaminosis D in HIV-Infected Subjects with and without Low Bone Mineral Density. Future Virology. 7(11). 1127–1134. 2 indexed citations
15.
Bonjoch, Anna, Carla Estany, Núria Pérez‐Álvarez, et al.. (2010). High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study. AIDS. 24(18). 2827–2833. 134 indexed citations
16.
Bonjoch, Anna, Beatriz Bayés, Jordi Puig, et al.. (2010). Validation of estimated renal function measurements compared with the isotopic glomerular filtration rate in an HIV-infected cohort. Antiviral Research. 88(3). 347–354. 23 indexed citations
17.
Negredo, Eugènia, Óscar Miró, Glòria Garrabou, et al.. (2009). Improvement of Mitochondrial Toxicity in Patients Receiving a Nucleoside Reverse‐Transcriptase Inhibitor–Sparing Strategy: Results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA). Clinical Infectious Diseases. 49(6). 892–900. 36 indexed citations
18.
Negredo, Eugènia, Jordi Puig, Manuel Medina, et al.. (2009). Four-Year Safety with Polyacrylamide Hydrogel to Correct Antiretroviral-Related Facial Lipoatrophy. AIDS Research and Human Retroviruses. 25(4). 451–455. 25 indexed citations
19.
Negredo, Eugènia, et al.. (2007). Therapeutic management of bone demineralization in the HIV-infected population. AIDS. 21(6). 657–663. 8 indexed citations
20.
Negredo, Eugènia, Juan Carlos Martínez, Eva Martínez, et al.. (2006). Reconstructive Treatment for Antiretroviral-Associated Facial Lipoatrophy: A Prospective Study Comparing Autologous Fat and Synthetic Substances. AIDS Patient Care and STDs. 20(12). 829–837. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sherry Claxton Breakdown of academic impact, for papers by Alan Macken Breakdown of academic impact, for papers by Julia Purdy Breakdown of academic impact, for papers by Janne Jensen Breakdown of academic impact, for papers by G. Calvo Breakdown of academic impact, for papers by Tania Mudrikova Breakdown of academic impact, for papers by Matthew R. Gingo Breakdown of academic impact, for papers by Jules Levin Breakdown of academic impact, for papers by Yuaner Wu Breakdown of academic impact, for papers by Pairoj Chattranukulchai
Rankless by CCL
2026